Biopolymers for Tissue Engineering and Regenerative Medicine

Tissue engineering is the immense area of research in recent years because of its vast potential in the repair or replacement of impaired tissues and organs. The present research will focus on scaffolds as they are one of the three most important factors, including seed cells, growth hormones and scaffolds in tissue engineering. Among the polymers used in tissue engineering, polyhydroxy esters (such as PLA, PGA, and PLGA) have extensive attention for a variety of biomedical applications. Besides, PCL has been widely used as a tissue engineering scaffold. Scaffolds have been used for tissue engineering such as bone, cartilage, ligament, skin, vascular tissues, neural tissues, and skeletal muscle and as vehicle for the delivery of drugs, proteins, and DNA. The worldwide market for tissue engineering and regeneration products is expected to reach USD 11.5 billion by 2022.

  • Tissue engineering and Regenerative medicine
  • Whole organ engineering and approaches
  • Bone and cartilage tissue engineering
  • Scaffolds
  • Novel approaches in guided tissue regeneration
  • Biopolymer methods in Cancer therapy
  • Crosslinking Biopolymers for Advanced Drug Delivery
  • Encapsulation vs. Polymer Therapeutics
  • Chitosan-Polyvinyl Alcohol-Ampicillin
  • Nanopharmaceuticals and nanomedicine
  • Polyamidoamine Nanoparticles for oral drug administration
  • Nanodelivery systems

Related Conference of Biopolymers for Tissue Engineering and Regenerative Medicine

Biopolymers for Tissue Engineering and Regenerative Medicine Conference Speakers